JCTLM: Traceability, education and promotion. www.jctlm.org. Accessed 8 Feb 2017.
ISO 15189:2012 Medical laboratories – requirements for quality and competence. ISO, Geneva, Switzerland, 2012.Google Scholar
ISO Guide 34:2009. General requirements for the competence of reference material producers, 3rd ed. Geneva, Switzerland: ISO, 2009.Google Scholar
ISO 15194:2009. In vitro diagnostic medical devices – measurement of quantities in samples of biological origin – requirements for certified reference materials and the content of supporting documentation, 2nd ed. Geneva, Switzerland: ISO, 2009.Google Scholar
ISO 17511:2003 In vitro diagnostic medical devices – measurement of quantities in biological samples – metrological traceability of values assigned to calibrators and control materials ISO, Geneva, Switzerland, 2003.Google Scholar
JCTLM database of reference materials and measurement procedures www.bipm.org/jctlm/. Accessed 17 Jan 2017.
WHO catalogue of blood products and related biologicals http://www.who.int/bloodproducts/catalogue/en. Accessed 17 Jan 2017.
Myers GL, Cooper GR, Winn CL, Smith SJ. The CDC – National Heart, Lung and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clin Lab Med 1989;9:105–35.PubMedGoogle Scholar
Myers GL, Kimberly MM, Waymack PP, Smith SJ, Cooper GR, Sampson EJ. A reference laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem 2000;46:1762–72.PubMedGoogle Scholar
Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in US deaths from coronary disease 1980–2000. N Engl J Med 2007;356:2388–98.Web of ScienceCrossrefGoogle Scholar
Hoerger TJ, Wittenborn JS, Young W. A cost-benefit analysis of lipid standardization in the United States. Prev Chron Dis 2011;8:A136.Google Scholar
Hoelzel W, Weycamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, et al. IFCC Reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan and Sweden: a method comparison study. Clin Chem 2004;50:166–74.PubMedCrossrefGoogle Scholar
IFCC network laboratories for HbA1c. www.ifcchba1c.net. Accessed 17 Jan 2017.
Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO publications, Geneva, Switzerland, 2011.Google Scholar
Weykamp C, John G, Gillery P, English E, Ji L, Lenters-Westra E, et al. Investigation of 2 models to set and evaluate quality targets for HbA1c: biological variation and sigma-metrics. Clin Chem 2015;61:752–9.PubMedCrossrefGoogle Scholar
Skugor M, Manjula Gupta M, Navaneethan SD. Evolution of current state of assays for measuring parathyroid hormone. Biochem Med 2010;20:221–8.Google Scholar
Almond A, Ellis AR, Walker SW. Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease. Ann Clin Biochem 2012;49:63–7.Web of SciencePubMedCrossrefGoogle Scholar
Sturgeon CM, Sprague SM, Metcalfe W. Variation in parathyroid hormone immunoassay results – a critical governance issue in the management of chronic kidney disease Nephrol Dial Transplant 2011;26:3440–5.PubMedGoogle Scholar
Daniel Y, Henthorn J. Sickle cell and thalassaemia: handbook for laboratories. NHS Sickle Cell and Thalassaemia Screening Programme 2012, 3rd ed. ISBN 13: 978-0-9565846-8-7.Google Scholar
Miller WG, Myers GL, Gantzer ML, Kahn SE, Schönbrunner ER, Thienpont LM, et al. Roadmap for Harmonization of Clinical Laboratory Measurement Procedures. Clin Chem 2011;57:1108–17.Web of ScienceCrossrefPubMedGoogle Scholar
International consortium for harmonization of clinical laboratory results (ICHCLR). www.harmonization.net. Accessed 08 Feb 2017.
About the article
Published Online: 2017-04-13
Published in Print: 2017-07-26
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.